SNY Stock Recent News

TEVA reports decent third-quarter results. The company raises its revenue guidance for 2023 for the second time this year while keeping the EPS range intact.

French prosecutors have opened a preliminary investigation into multinational pharmaceutical company Sanofi over possible market manipulation.

Sanofi's third-quarter results weren't great, and the company announced a business separation. The biotech will lower its operating income margin target for 2025, which scared off many investors.

MeiraGTx Holdings PLC (NASDAQ:MGTX) shares gained more than 25% after it announced Sanofi SA (ADR) (NYSE:SNY), a pharma giant best known for its vaccines, is purchasing 4 million of the gene company's shares at a price of $7.50 per share for a total $30 million investment. MeiraGTx stock was up 25.4% at US$4.64 late morning on Monday, while Sanofi shares gained 3.5% at US$44.63.

Sanofi (SNY) shares are trending higher after plummeting last Friday, after the pharmaceutical company missed third-quarter earnings expectations, losing over $21 billion in market value. Sanofi announced plans to spin off its consumer health division, with CEO Paul Hudson stating the spinoff aims to enhance the company's "cost structure" and aid them in "becoming a pure play biopharma company.

Shares of MeiraGTx Holdings PLC MGTX, -4.88% jumped 14% premarket on Monday after the gene therapy company announced that French drugmaker Sanofi SNY, -19.13% has made a $30 million investment.

Sanofi (NASDAQ:SNY ) Q3 2023 Earnings Conference Call October 27, 2023 9:00 AM ET Company Participants Eva Schaefer-Jansen - Head of Investor Relations Paul Hudson - Chief Executive Officer Jean-Baptiste de Chatillon - Executive Vice President, Chief Financial Officer Houman Ashrafian - Global Head of R&D Julie Van Ongevalle - Executive Vice President, Consumer Healthcare Brian Ford - Head Specialty Care, North America and US Country Lead Thomas Triomphe - Executive Vice President, Vaccines Olivier Charmeil - Executive Vice President, General Medicines Conference Call Participants Luisa Hector - Berenberg Emily Field - Barclays Peter Welford - Jefferies Graham Parry - BofA Timothy Anderson - Wolfe Peter Verdult - Citi David Risinger - Leerink Florent Cespedes - Societe Generale Simon Baker - Redburn Seamus Fernandez - Guggenheim Richard Vosser - JPMorgan Eva Schaefer-Jansen [starts abruptly] You have joined the meeting as an attendee and will be muted throughout the meeting. This meeti

Sanofi (SNY) beats third-quarter estimates for earnings but misses the same for sales. It announces plans to separate its Consumer unit into a new public listed company.

Sanofi (NYSE: SNY ) stock fell about 15% overnight after it predicted slower profit growth next year. The French drug company also said it will follow rivals and spinoff its consumer health business.

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, spin off of its consumer health care business, growth outlook, and more.